Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -49.76% |
| Q3 2025 | 255.15% |
| Q2 2025 | 16.56% |
| Q1 2025 | -346.97% |
| Q4 2024 | 842.86% |
| Q3 2024 | -73.08% |
| Q2 2024 | 113.98% |
| Q1 2024 | 66.00% |
| Q4 2023 | -147.51% |
| Q3 2023 | -2355.56% |
| Q2 2023 | 97.29% |
| Q1 2023 | -331.17% |
| Q4 2022 | -175.00% |
| Q3 2022 | 94.37% |
| Q2 2022 | -6.88% |
| Q1 2022 | -369.70% |
| Q4 2021 | 74.81% |
| Q3 2021 | -793.18% |
| Q2 2021 | -106.13% |
| Q1 2021 | 624.09% |
| Q4 2020 | 76.90% |
| Q3 2020 | -297.67% |
| Q2 2020 | 78.57% |
| Q1 2020 | 984.21% |
| Q4 2019 | -112.03% |
| Q3 2019 | -49.84% |
| Q2 2019 | 377.27% |
| Q1 2019 | -82.54% |
| Q4 2018 | 384.62% |
| Q3 2018 | -83.72% |
| Q2 2018 | 316.52% |
| Q1 2018 | -65.15% |
| Q4 2017 | 40.43% |
| Q3 2017 | -35.79% |
| Q2 2017 | -10.95% |
| Q1 2017 | 30.89% |
| Q4 2016 | 1182.76% |
| Q3 2016 | -105.14% |
| Q2 2016 | 22.88% |
| Q1 2016 | -11.90% |